Supplemental Table 1 from A Blueprint to Advance Colorectal Cancer Immunotherapies

Figshare2017-11-01 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Supplemental_Table_1_from_A_Blueprint_to_Advance_Colorectal_Cancer_Immunotherapies/22536961 数据链接链接失效反馈

官方服务：

资源简介：

S1. Therapeutic strategies and corresponding laboratory tests.

创建时间：

2017-11-01

Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer

结直肠癌免疫治疗

RAS突变肿瘤

The purpose of this study is to determine safety and anti-tumor immune activation generated by TG02 and Granulocyte macrophage colony stimulating factor (GM-CSF), first as monotherapy (Part I), therea

NIAID Data Ecosystem90

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

结直肠癌免疫治疗

MSI微卫星不稳定性

PD1 antibody is now recommended for dMMR/MSI-H metastatic colorectal cancer patients as second line. Chemoradiotherapy is standand treatment for locally advanced rectal cancer and is also recommended

NIAID Data Ecosystem50

Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Patients With Colorectal Cancer

结直肠癌免疫治疗

新辅助治疗

This study will evaluate the safety, and tolerability of neo-adjuvant treatment with tislelizumab in participants with early-stage (Stage II-III) Microsatellite Instability-High (MSI-H) or Mismatch Re

NIAID Data Ecosystem40

The reintroduction of cetuximab in combination with toripalimab in RAS/BRAF wild-type advanced colorectal cancer: a phase II clinical study

结直肠癌免疫治疗

靶向联合疗法

Interventions: toripalimab+cetuximab: toripalimab+cetuximab Primary outcome(s): overall survival Study Design: Single arm

NIAID Data Ecosystem60

Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors

微生物抗肿瘤

结直肠癌免疫治疗

Despite overall success, the efficacy of T-cell checkpoint inhibitors is still limited to a minority of cancer patients. Recently, intestinal microbiota was found to critically modulate anti-cancer im

NIAID Data Ecosystem40

Supplemental Table 1 from A Blueprint to Advance Colorectal Cancer Immunotherapies

资源简介：

相关数据集